A bulging fontanelle appears in 95 percent of infants with hydrocephalus. The condition affects roughly one million people in the United States, presenting with symptoms from a shuffling gait to memory loss across a lifetime.
Key Takeaways
- Enlarged head circumference at birth in 90% congenital cases
- Irritability and vomiting common in 70% infants
- Downward gaze palsy (sunsetting eyes) in 60% pediatric cases
- Hydrocephalus affects 1 in every 770 live births worldwide
- In the United States, about 1 million people live with hydrocephalus
- Incidence of congenital hydrocephalus is 3-4 per 1,000 live births
- Chiari malformation type II has 90% hydrocephalus association
- Intraventricular hemorrhage causes 40% of pediatric hydrocephalus
- Aqueductal stenosis due to congenital malformation in 25% cases
- Survival to adulthood 80-90% with early shunting
- Shunt malfunction leads to 40% readmissions yearly
- Cognitive outcomes normal in 50% early treated congenital
- VP shunt is primary treatment in 95% cases
- Endoscopic third ventriculostomy (ETV) success 60-80% in select cases
- Shunt infection rate 5-15% within first year
Hydrocephalus affects about 1 in 770 births worldwide, with NPH often causing memory, gait, and bladder problems.
Related reading
01 · Category
Clinical Presentation30 stats
01
Enlarged head circumference at birth in 90% congenital cases
02
Irritability and vomiting common in 70% infants
03
Downward gaze palsy (sunsetting eyes) in 60% pediatric cases
04
Gait disturbance classic triad in 50-70% NPH adults
05
Cognitive impairment in 60% NPH patients
06
Headache present in 80% older children and adults
07
Urinary incontinence in 50% NPH triad
08
Seizures occur in 30% of pediatric hydrocephalus
09
Bulging fontanelle in 95% infants under 1 year
10
Papilledema on fundoscopy in 40-60% acute cases
11
Memory loss and dementia-like symptoms in 70% NPH
12
Lethargy in 75% neonates with hydrocephalus
13
Sixth nerve palsy in 20-30% cases
14
Delayed developmental milestones in 85% untreated infants
15
Brisk reflexes and spasticity in 50%
16
Nausea and vomiting in 65% school-age children
17
Visual disturbances in 40% chronic cases
18
Apnea and bradycardia in 30% severe infantile cases
19
Psychomotor retardation in 60% post-treatment if delayed
20
Balance issues and falls in 80% NPH before treatment
21
High-pitched cry in 70% infants
22
MRI shows ventricular enlargement in 100% diagnosed cases
23
Evans' index >0.3 indicates hydrocephalus on CT
24
Lumbar puncture shows normal pressure in 90% NPH
25
Ultrasound detects ventriculomegaly in 95% prenatal cases
26
CSF flow void on MRI phase-contrast in 80% idiopathic NPH
27
Head circumference >97th percentile in 90% congenital
28
Radionuclide cisternography positive in 60% NPH
29
ICP monitoring elevated >20 cmH2O in 70% acute
30
Tap test improves gait in 50-80% NPH responders
Interpretation
Clinical Presentation Interpretation
In the clinical presentation of hydrocephalus, enlarged head circumference at birth shows up in 90% of congenital cases and headaches affect 80% of older children and adults, making these early and later symptoms the most consistently observed patterns.
02 · Category
Epidemiology30 stats
01
Hydrocephalus affects 1 in every 770 live births worldwide
02
In the United States, about 1 million people live with hydrocephalus
03
Incidence of congenital hydrocephalus is 3-4 per 1,000 live births
04
Acquired hydrocephalus occurs in 1-2% of patients after traumatic brain injury
05
Normal pressure hydrocephalus (NPH) prevalence increases with age, affecting 1-5% of people over 65
06
Pediatric hydrocephalus incidence is 0.5-1.5 per 1,000 live births in developed countries
07
Global incidence of hydrocephalus is estimated at 6 per 10,000 births
08
In adults, NPH accounts for 5-10% of dementia cases
09
Hydrocephalus occurs in 20-30% of premature infants weighing less than 1,500g
10
Annual incidence of post-infectious hydrocephalus in children in developing countries is up to 50 per 100,000
11
Spina bifida associated hydrocephalus affects 80-90% of cases
12
Hydrocephalus prevalence in adults over 70 is approximately 2%
13
Congenital hydrocephalus represents 60% of all pediatric hydrocephalus cases
14
Tumor-related hydrocephalus occurs in 10-15% of pediatric brain tumors
15
Incidence of hydrocephalus after intraventricular hemorrhage in preterm infants is 25-30%
16
NPH is diagnosed in 1.3% of individuals over 65 in community studies
17
Hydrocephalus affects males and females equally in congenital forms
18
Global burden: 400,000 new pediatric cases annually
19
In sub-Saharan Africa, hydrocephalus incidence from neonatal sepsis is 100 per 100,000
20
Aqueductal stenosis accounts for 20% of congenital hydrocephalus
21
Hydrocephalus in myelomeningocele is present in 85% at birth
22
Adult-onset hydrocephalus prevalence is 0.2% in general population
23
Ventriculitis leads to hydrocephalus in 40% of cases
24
Incidence of iatrogenic hydrocephalus post-neurosurgery is 5-10%
25
Hydrocephalus in Alzheimer's patients overlaps in 10-20%
26
Preterm infant hydrocephalus rate is 15-20% in NICUs
27
Genetic forms of hydrocephalus occur in 1-2% of cases
28
Seasonal variation shows higher incidence in winter births, 10% increase
29
Hydrocephalus lifetime risk in general population is 1:1000
30
Neural tube defects link to hydrocephalus in 70% cases
Interpretation
Epidemiology Interpretation
From an epidemiology standpoint, hydrocephalus is relatively uncommon at birth, with congenital cases running about 3 to 4 per 1,000 live births, yet it becomes more frequent across the lifespan, particularly as normal pressure hydrocephalus affects about 1 to 5 percent of people over 65.
03 · Category
Etiology29 stats
01
Chiari malformation type II has 90% hydrocephalus association
02
Intraventricular hemorrhage causes 40% of pediatric hydrocephalus
03
Aqueductal stenosis due to congenital malformation in 25% cases
04
Meningitis leads to hydrocephalus in 10-30% of bacterial cases in children
05
Spina bifida myelomeningocele causes obstructive hydrocephalus in 80%
06
Prematurity and germinal matrix hemorrhage risk factor for 50% cases
07
X-linked hydrocephalus from L1CAM mutation in 5-10% familial cases
08
Tumors (e.g., medulloblastoma) obstruct CSF flow in 15% pediatric cases
09
Post-traumatic etiology in 11% of adult hydrocephalus
10
Viral infections like CMV cause congenital hydrocephalus in 10%
11
Dandy-Walker malformation associated in 70% with hydrocephalus
12
Subarachnoid hemorrhage leads to communicating hydrocephalus in 20%
13
Genetic syndromes (e.g., Apert) have 40-60% hydrocephalus rate
14
Neurocysticercosis causes hydrocephalus in 50% endemic areas
15
Idiopathic intracranial hypertension misdiagnosed as hydrocephalus in 5%
16
Brainstem malformations cause 10% congenital cases
17
Post-meningitis adhesions block CSF in 20-30%
18
Arachnoid cysts lead to hydrocephalus in 10-15%
19
Lyme disease neuroborreliosis causes 5% hydrocephalus cases
20
Craniosynostosis syndromes increase risk 30%
21
Neonatal sepsis etiology in 25% developing world cases
22
Familial aqueductal stenosis in 2-5% genetic hydrocephalus
23
Toxoplasmosis congenital infection causes 15% cases
24
Head trauma acute hydrocephalus in 47% severe cases
25
Vein of Galen malformation associated 70%
26
Tuberculosis meningitis leads to 30-50% hydrocephalus
27
Joubert syndrome has 20% hydrocephalus incidence
28
Posterior fossa tumors cause 25% pediatric hydrocephalus
29
Fetal alcohol syndrome risk factor for 10%
Interpretation
Etiology Interpretation
From an etiology perspective, the causes of hydrocephalus are strongly concentrated in a few conditions, with Chiari malformation type II accounting for 90% of associations and spina bifida myelomeningocele causing obstructive hydrocephalus in 80%, while intraventricular hemorrhage, prematurity with germinal matrix hemorrhage, and bacterial meningitis contribute smaller but important shares of 40%, 50%, and 10 to 30% respectively.
More related reading
04 · Category
Prognosis22 stats
01
Survival to adulthood 80-90% with early shunting
02
Shunt malfunction leads to 40% readmissions yearly
03
Cognitive outcomes normal in 50% early treated congenital
04
NPH shunt response 60-80% gait improvement
05
Mortality 10-20% in untreated infantile cases
06
Infection mortality 5-10% in shunted patients
07
IQ average 85-90 in treated pediatric cohorts
08
Visual impairment permanent in 20% post-shunt
09
Epilepsy develops in 25-30% long-term
10
NPH dementia reversible in 50% after shunting
11
Shunt revisions lifetime average 4-5 times
12
5-year survival 95% in shunted children
13
Motor deficits persist in 40% despite treatment
14
ETV long-term patency 70% at 5 years
15
Obesity risk increased 2-fold in shunted patients
16
Psychosocial issues in 60% adolescents with shunts
17
Overdrainage syndrome in 10-20% vertical shunts
18
Academic underachievement in 50% school-age
19
Adult independence achieved in 70% early treated
20
Slit ventricle syndrome in 10% chronic shunted
21
Quality of life improved 75% post-NPH shunt
22
Premature closure of sutures in 30% untreated
Interpretation
Prognosis Interpretation
From a prognosis standpoint, early shunting is linked to high survival to adulthood of 80 to 90 percent, while the main ongoing risk is shunt malfunction driving about 40 percent readmissions each year.
05 · Category
Treatment26 stats
01
VP shunt is primary treatment in 95% cases
02
Endoscopic third ventriculostomy (ETV) success 60-80% in select cases
03
Shunt infection rate 5-15% within first year
04
Ventriculoperitoneal shunt used in 90% pediatric patients
05
Programmable shunt valves reduce revisions by 40%
06
ETV preferred in obstructive hydrocephalus 70% success
07
Shunt revision surgery needed in 50% within 2 years
08
Antibiotic-impregnated shunts lower infection 50-60%
09
Lumboperitoneal shunt for NPH in 20-30% cases
10
Stereotactic placement improves accuracy to 95%
11
Furosemide and acetazolamide used adjunctively in 40%
12
Shunt tap for diagnosis in 30% malfunction suspicions
13
Endoscopic choroid plexus coagulation success 50% in infants
14
MRI-compatible shunts in 80% modern implants
15
Serial lumbar punctures temporary in 10-20% NPH
16
Tumor resection combined with ETV in 60% cases
17
Shunt independence after ETV 70% in aqueductal stenosis
18
Gravitational valves effective in 65% upright patients
19
Intraoperative navigation used in 50% complex cases
20
Shunt removal and external ventricular drain in infections 90%
21
Ventriculoatrial shunt alternative in 5-10% abdominal failures
22
Laser ablation for cysts pre-shunt in 30%
23
Multidisciplinary follow-up reduces complications 25%
24
Telemetric ICP monitors in 20% refractory cases
25
Fenestration of cysts endoscopically 70% success
26
Shunt overdrainage prevented by antisiphon in 40%
Interpretation
Treatment Interpretation
In the treatment of hydrocephalus, VP shunts dominate care with use in 95% of cases and 90% of pediatric patients, though newer approaches like ETV show 60 to 80% success in selected cases and programmable valves can cut revision rates by 40%.
report visual · Breakdown
Hydrocephalus: presentation vs burden
Common clinical signs in hydrocephalus (mostly infants/children) compared with how widespread the condition is.
90%
Enlarged head circumference at birth in 90% congenital cases
10%
Seasonal variation shows higher incidence in winter births, 10% increase
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Isabelle Moreau. (2026, February 13). Hydrocephalus Statistics. Gitnux. https://gitnux.org/hydrocephalus-statistics
MLA
Isabelle Moreau. "Hydrocephalus Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/hydrocephalus-statistics.
Chicago
Isabelle Moreau. 2026. "Hydrocephalus Statistics." Gitnux. https://gitnux.org/hydrocephalus-statistics.
Sources & references
23 datasets cited across this report · attribution is report-level